68
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
688621.SS · SHH
¥68.31 -1.85% (-¥1.29)
1M +5.06%
Market Cap ¥7.82B
P/E Ratio 186.96x
Div. Yield 0.27%
ROE 3.46%
Bulios Fair Price
¥66.27
3.0% downside
Current Price
¥68.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 688621.SS is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
9 /100
Expensive P/E 186.96x
EV/EBITDA 173.50x
P/S 7.43x
Growth
86 /100
Growing EPS growth 9.93%
Rev. growth 21.64%
FCF growth 720.56%
Profitability
29 /100
Weak Gross margin 53.75%
Net margin 3.97%
Op. margin 1.89%
Quality
13 /100
Poor ROIC 0.10%
ROE 3.46%
ROA 1.85%
Debt
43 /100
Moderate Debt/Equity 0.57x
Current ratio 1.71x
Int. coverage 1.03x
Stability
81 /100
Stable Beta -0.14x
Rev. volatility 13.61%
EPS volatility 12.72%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 688621.SS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yujing Liu
Employees
1,335
Headquarters
Beijing